During the past decade, DCT - Stone Oak, LLC dba Discovery Clinical Trials conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 15 clinical trials were completed, i.e. on average, 78.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" #1 sponsor was "Pfizer" with 3 trials, followed by "ADMA Biologics, Inc." with 2 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Curatek Pharmaceuticals, LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" are "Endometriosis" (3 trials), "Migraine" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Osteoarthritis, Knee" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" in a lesser frequency.

Most popular intervention types in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" are "Drug" (25 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "ABP-450" (2 trials) and "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials). Other intervention names were less common.

The vast majority of trials in "DCT - Stone Oak, LLC dba Discovery Clinical Trials" are 18 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "DCT - Stone Oak, LLC dba Discovery Clinical Trials". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in DCT - Stone Oak, LLC dba Discovery Clinical Trials, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in DCT - Stone Oak, LLC dba Discovery Clinical Trials, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".